Navigation Links
ReSearch Pharmaceutical Services, Inc. to Present at Jefferies 2010 Global Healthcare Conference
Date:1/23/2010

FORT WASHINGTON, Pa., Jan. 22 /PRNewswire-FirstCall/ -- ReSearch Pharmaceutical Services, Inc. (RPS) today announced that Daniel Perlman, Chief Executive Officer and Steven Bell, Chief Financial Officer, will present at the Jefferies 2010 Global Healthcare Conference, which will be held January 25–27, 2010 in New York City.  

The presentation is scheduled for Wednesday, January 27, 2010, at 11:45 am, EST.  Mr. Perlman will also participate in a CRO Panel Discussion – Trends in Clinical Research at 12:25 pm, EST.

About ReSearch Pharmaceutical Services, Inc. (RPS)

Headquartered in Fort Washington, Pennsylvania, with subsidiary offices across Latin America, Europe and Asia, RPS is a next generation CRO and a leading provider of integrated clinical development and enhanced full-service outsourcing solutions to the bio-pharmaceutical industry.  RPS providers services in connection with the design, initiation and management of clinical trials programs that are required to obtain regulatory approval to market bio-pharmaceutical products.  Our innovative business model combines the expertise of a traditional CRO with the ability to provide flexible outsourcing solutions that are fully integrated within our clients' clinical drug development infrastructure.  This approach was designed to meet the varied needs of small, medium and large bio-pharmaceutical companies.  

SOURCE ReSearch Pharmaceutical Services, Inc.

RELATED LINKS
http://www.rpsweb.com

'/>"/>

SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers welcome new multiple sclerosis drug
2. Barrow researchers receive more than $2 million in NIH grants for nicotine studies
3. New research will examine link between childhood asthma, sleep and school performance
4. Barrow researcher reports that slow breathing reduces pain
5. Research Indicates Participants in Incentive-Based Health Promotion Programs Have Lower Healthcare Costs
6. Researchers discover method to objectively identify PTSD
7. Mouse Study May Advance Multiple Sclerosis Research
8. Researchers find a treatment for deadly brain tumor
9. Childhood Apraxia of Speech Association of North America Awards Treatment Research Grant to University of New Mexico/PROMPT Institute
10. Concussions not taken seriously enough: McMaster researcher
11. Researchers find new insights into inherited retinal disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , ... December 09, 2016 , ... "I have gout, ... used this old family recipe, which is meant to relieve gout and pain caused ... me a 12-hour energy boost every time. It relieved what VA doctors called the ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy ... in New York, NY, on December 3rd, to benefit Holy Name Medical Center's ... annual event, which raised over $1 million - the largest event in the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida ... Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This ... Only a few hospitals and facilities have earned this distinction. This is the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec 8, 2016 Research and Markets has announced ... report to their offering. ... This report analyzes the worldwide markets for Endodontic Supplies ... Canada , Japan , Europe ... Rest of World. Annual estimates and forecasts are provided for the ...
(Date:12/8/2016)... Dec. 8, 2016   TriNetX , the ... Children,s Hospital signed a membership agreement to ... development of new cures. The TriNetX ... 57 million patients globally, biopharmaceutical companies and contract ... improve protocol design, site selection, patient recruitment, and ...
(Date:12/8/2016)... 8, 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... today announced positive results from a Phase 3, ... the safety and efficacy of IDP-118 (halobetasol propionate ... psoriasis. Within the Phase 3 ... severe psoriasis, IDP-118 showed statistical significance to vehicle ...
Breaking Medicine Technology: